Prostate Cancer Biomarker Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2024 February 06
SKU : PH4116
180 pages
Report Summary
Table of Contents
List of Tables & Figures
Buy this report
Single User
$4350
Multiple User
$4850
Enterprise User
$7850
Request new version
FAQ’s
What is the Projected CAGR value of the Prostate Cancer Biomarker Market?
Prostate Cancer Biomarker Market is expected to grow at a CAGR of 12.61% during the forecast period 2023-2030.
Which region controlled the global market during 2023-2030?
North America region Controls the Prostate Cancer Biomarker Market during 2023-2030.
What are the treatment options for prostate cancer?
The treatment for prostate cancer depends on the stage of the cancer, the patient's age and health, and the patient's preferences. Treatment options are active surveillance, radiation therapy, surgery, hormone therapy and chemotherapy.
Who are the key players in Prostate Cancer Biomarker Market?
Major players are BioVision Inc., QIAGEN N.V., Roche Diagnostics Limited, Beckman Coulter Inc and Myriad Genetics, Sanofi-Aventis, Pfizer Inc and MDx Health.
Related Reports
pharmaceuticalsProstate Cancer Market Size, Share, Industry, Forecast and outlook 2024-2031
Published: 2024 January 04
Starting from
$4350
medical-devicesCancer Biomarkers Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 February 01
Starting from
$4350
pharmaceuticalsProstate Cancer Diagnostics Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 January 18
Starting from
$4350
clinical-diagnosticsGenomic Biomarker Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2023 May 24
Starting from
$4350
clinical-diagnosticsCardiac Biomarkers Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2023 March 23
Starting from
$4350
clinical-diagnosticsRenal Biomarkers Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2023 June 06
Starting from
$4350